期刊文献+

靶向组蛋白去乙酰化酶新型化合物的体外抗肿瘤活性筛选

Screening the in Vitro Anti-tumor Activities of Novel Synthetics Targeting to Histone Deacetylases
下载PDF
导出
摘要 目的针对组蛋白去乙酰化酶(HDAC),自行设计合成系列化合物,着重对其体外抗肿瘤活性进行筛选,为进一步优化设计提供借鉴。方法首先利用MTT法测定各化合物对不同肿瘤细胞株增殖能力的影响,再对重点化合物进行组蛋白去乙酰化酶抑制活性测定。结果MTT结果显示,化合物H6和H99均显示出较好的肿瘤细胞增殖抑制效应;相应的HDAC活性检测表明,二者亦具有肯定的HDAC抑制效应。结论化合物H6和H99具有明显的体外抗瘤活性,值得深入研究。 Aim To evaluate the antitumor effects of the synthetics targeting to histone deacetylases (HDAC).Methods The anti-proliferative activities of the synthetics on various human tumor cells were screened using MTT assay in vitro.Then,some screened synthetics were detected for their inhibition on HDAC.Results The synthetics H6 and H99 exert their inhibitive effects on the proliferation of several human cancer cell lines.Also,they have the properties to inhibit the activities of HDAC.Conclusion It has been proven that the synthetics H6 and H99 have marked anti-tumor effects in vitro.
出处 《解放军药学学报》 CAS 2009年第6期482-485,共4页 Pharmaceutical Journal of Chinese People's Liberation Army
基金 国家自然科学基金资助项目 No.30772628
关键词 组蛋白去乙酰化酶 抗瘤活性 体外 histone deacetylases anti-tumor activity in vitro
  • 相关文献

参考文献15

  • 1Kelly WK, O' Conner OA, Marks PA. Histone deacetylase inhibitors : from target to clinical trials[J]. Expert Opin Investing Drugs ,2002, 11(12) :1695. 被引量:1
  • 2Kramer OH, Gottlicher M, Heinzel T. Histone deacetylase as a therapeutic target [ J ]. Trends Endocrinol Metab ,2001 , 12 (7) :294. 被引量:1
  • 3Tsuruteui J ,Soda H,Oka M, et al. Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell hmg cancer lines and drug resistant sublines[J], Int J Cancer ,2003,104(2) :238. 被引量:1
  • 4Brinkmenn H,Dahler AL,Popa C, et al. Histone hyperacetyiation induced by histone deacetylase inhibitors is not sufficient to cause growth inhibition in human dermal fibroblasts[ J]. J Biol Chem , 2001,276(25 ) :22491. 被引量:1
  • 5Nervi C, Borello U,Fazi F, et al. Inhibition of histone deacetylase activity by trichostatin A modulates gene expression during mouse embryogenesis without apparent toxicity[ J ]. Cancer Res ,2001,61 (4) :1247. 被引量:1
  • 6Williams RJ,Trichostatin A. An inhibitor of histone deacetylase, inhibits hypoxia-induced angiogenesis [ J ]. Expect Opin Investig Drugs ,2001,10(8) :1571. 被引量:1
  • 7Kwon HJ, Kim MJ. Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis [ J ]. Int J Cancer ,2002,97 ( 3 ) :290. 被引量:1
  • 8Deroanne CF, Bonjean K, Servotte S, et al. Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling[ J]. Oncogene ,2002,21 (3) :427. 被引量:1
  • 9Sawa H, Murakami H, Ohshima Y, et al. Histone deacetylase inhibitors such as sodium butyrate and trichostatin A inhibit vascular endothelial growth factor (VEGF) secretion from human glioblastoma cells [ J ]. Brain Tumor Pathol ,2002,19 (2) :77. 被引量:1
  • 10Galina VK, Gyorgy F, Jennifer LG, et al. Phosphorus-based SAHA analogues as histone deacetylase inhibitors [ J ]. Org Lett, 2003,5 ( 17 ): 3053. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部